438.66
price down icon1.52%   -6.77
pre-market  Vorhandelsmarkt:  438.66  
loading

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

pulisher
Nov 03, 2025

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease - The Joplin Globe

Nov 03, 2025
pulisher
Nov 03, 2025

United Therapeutics (Nasdaq: UTHR) starts EXPAND with first UKidney xenotransplant - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Can technical indicators confirm United Therapeutics Corporation’s reversalWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 01, 2025

United Therapeutics Hits Day High with 9.63% Surge in Stock Price - Markets Mojo

Nov 01, 2025
pulisher
Nov 01, 2025

Is United Therapeutics Corporation (UTH) stock a top dividend aristocrat candidateRisk Management & Reliable Entry Point Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

MSN Money - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

United Therapeutics Corp. Hits New 52-Week High of $479.50 - Markets Mojo

Nov 01, 2025
pulisher
Nov 01, 2025

United Therapeutics posts record revenue but misses Q3 earnings expectations - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Focus Partners Advisor Solutions LLC Buys Shares of 1,440 United Therapeutics Corporation $UTHR - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation - MSN

Oct 31, 2025
pulisher
Oct 31, 2025

United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

3rd Circ. Preview: BMW, MiLB And Sandoz Top Nov. Lineup - Law360

Oct 31, 2025
pulisher
Oct 31, 2025

United Therapeutics (NASDAQ:UTHR) Given New $423.00 Price Target at Wells Fargo & Company - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Assetmark Inc. Boosts Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Will United Therapeutics Corporation stock benefit from upcoming earnings reportsOptions Play & Technical Pattern Alert System - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

United Therapeutics Executives Sell Shares - TradingView

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Wells Fargo Maintains United Therapeutics (UTHR) Equal-Weight Recommendation - Nasdaq

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics (NASDAQ:UTHR) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics price target raised to $587 from $569 at RBC Capital - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics price target raised to $447 from $435 at Morgan Stanley - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics (UTHR) Earnings Transcript - AOL.com

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Silver Spring-based United Therapeutics reports Q3 earnings - Maryland Daily Record

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-31 23:58:52 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics Reports Record Q3 2025 Results - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus

Oct 30, 2025
pulisher
Oct 29, 2025

United Therapeutics: Q3 Earnings Snapshot - CT Insider

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics (NASDAQ:UTHR) COO Sells $9,393,750.00 in Stock - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Why Is United Therapeutics (UTHR) Stock Soaring Today - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Benzinga

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Q3 2025 Earnings ReportRevenue & Profit AnalysisNews and Statistics - IndexBox

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Q3 2025 Earnings: Profit Beats ForecastsNews and Statistics - IndexBox

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics (UTHR) Beats Q3 Earnings Estimates - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Grows Revenue, But Misses Earnings Forecast - Finimize

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Corp Q3 2025 Earnings: EPS of $7.16 Beats Es - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Corp Announces Rise In Q3 Bottom Line - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics misses Q3 expectations despite record revenue - Investing.com

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics misses Q3 expectations despite record revenue By Investing.com - Investing.com Philippines

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Q3 revenue misses estimates - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

UNITED THERAPEUTICS Corp SEC 10-Q Report - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

Sumitomo Mitsui Trust Group Inc. Has $28.81 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Corporation $UTHR Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

United Therapeutics Corp. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 29, 2025
pulisher
Oct 29, 2025

Will United Therapeutics Corporation stock outperform value stocksTrade Performance Summary & Community Verified Swing Trade Signals - fcp.pa.gov.br

Oct 29, 2025
pulisher
Oct 28, 2025

Can United Therapeutics Corporation stock resist sector downturnsPortfolio Risk Summary & AI Enhanced Market Trend Forecasts - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

How geopolitical tensions affect United Therapeutics Corporation stock2025 Support & Resistance & Daily Stock Trend Reports - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients - TipRanks

Oct 27, 2025
$20.52
price up icon 0.20%
$141.96
price down icon 0.87%
$10.53
price up icon 1.64%
$22.85
price up icon 3.16%
drug_manufacturers_specialty_generic RDY
$13.41
price up icon 0.90%
Kapitalisierung:     |  Volumen (24h):